Cite
MLA Citation
A Strik et al.. “P724 Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE).” Journal of Crohn's and colitis, vol. 12, n.d., pp. S477–S478. http://access.bl.uk/ark:/81055/vdc_100095499002.0x000011